#75 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
Clinicians treating older adults should understand that cannabis use in this population is increasing for manageable conditions like pain, sleep, and anxiety, requiring evidence-based counseling on efficacy and safety. The research published in JAMA Network Open provides clinical data on cannabis outcomes in seniors, enabling providers to have informed conversations about risks including drug interactions, fall risk, and cognitive effects that are particularly concerning in aging populations. Given the growing prevalence of cannabis use among older patients, clinicians need current evidence to address patient inquiries and make individualized recommendations rather than defaulting to dismissal or endorsement.
A recent study published in JAMA Network Open examined why older adults are increasingly using cannabis, particularly edible formulations, for managing pain, sleep disturbances, and mental health symptoms. The research found that older adults perceive cannabis as a “Goldilocks” option that occupies a middle ground between pharmaceutical interventions (which may have significant side effects and drug interactions in this population) and non-pharmacological approaches (which may be insufficiently effective). This shift reflects growing acceptance of cannabis among seniors seeking alternatives to opioids and sedating medications that carry elevated risks for falls, cognitive impairment, and polypharmacy complications. The preference for edibles in this demographic likely relates to their convenience, ease of dose control, and avoidance of respiratory effects from smoking. Clinicians caring for older adults should be aware that cannabis use in this population is driven by legitimate symptom management goals and should engage in open, non-judgmental conversations about cannabis use to understand dosing practices, potential drug interactions, and effects on balance and cognition. Understanding these patient motivations enables clinicians to provide better harm reduction counseling and to consider whether cannabis might be a reasonable component of individualized treatment plans for appropriate patients.
“What I’m seeing in my practice is that older adults are making a rational choice based on their lived experience: cannabis often provides meaningful relief from pain, insomnia, and anxiety with a side effect profile they find more tolerable than the alternatives, which for many means avoiding opioids, benzodiazepines, or additional polypharmacy. The research is finally catching up to what my patients have been telling me for years, and I can now discuss dosing, cannabinoid ratios, and drug interactions with the same evidence-based confidence I bring to any other medication.”
💊 As older adults increasingly use cannabis products for pain, sleep, and mood management, clinicians should recognize this trend reflects genuine symptom burden rather than recreational curiosity, yet evidence supporting efficacy and safety in this population remains limited and heterogeneous. The appeal of cannabis to older patients may stem from dissatisfaction with conventional medications—whether due to side effects, drug interactions, or perceived inadequacy—but practitioners should be cautious about viewing it as a risk-free alternative, since age-related pharmacokinetic changes, polypharmacy, and potential cognitive or cardiovascular effects create a distinct safety profile compared to younger users. Key confounders in interpreting patient preferences include marketing influences, peer recommendations, legal accessibility in some jurisdictions, and the difficulty older adults face in accessing rigorous clinical counseling about cannabis. Given these gaps, clinicians should engage in open, non-judgmental conversations with older patients about cannabis use, document its use in the
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
